Should all cases of lung cancer be presented at tumor board conferences?

Thoracic Surgery Clinics

Volumn 23, Issue 2, 2013, Pages 123-128

  Riquet, Marc ^a   Mordant, Pierre ^a   Henni, Mehdi ^a   Wermert, Delphine ^a   Fabre Guillevin, Elizabeth ^a   Cazes, Aurélie ^a   Le Pimpec Barthes, Françoise ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Lung cancer; Multidisciplinary team; Multimodality treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; FORCED EXPIRATORY VOLUME; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HISTOLOGY; HUMAN; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; MEDICAL DECISION MAKING; OVERALL SURVIVAL; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

CONGRESSES AS TOPIC; FRANCE; GUIDELINE ADHERENCE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT CARE TEAM; PROGNOSIS; QUALITY OF HEALTH CARE; REGISTRIES;

EID: 84875896319     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2013.01.003     Document Type: Review

References (30)

1. Wright F.C., De Vito C., Langer B., the Expert Panel on Multidisciplinary Cancer Conferences Standards, et al. Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer 2007, 43:1002-1010.
2. Ellis P.M. The importance of multidisciplinary team management of patients with non-small-cell lung cancer. Curr Oncol 2012, 19:S7-S15.
3. Depierre A. La réunion de concertation pluridisciplinaire. La Lettre du Pneumologue 2006, 9:168-170.
4. Dillman R.O., Chico S.D. Cancer patient survival improvement is correlated with the opening of a community cancer center: comparison with intramural and extramural benchmarks. J Oncol Pract 2005, 1:84-92.
5. Davis S., Wright P.W., Schulman S.F., et al. Participants in prospective randomised clinical trials for resected non-small cell lung cancer have improved survival compared with non participants in such trials. Cancer 1985, 56:1710-1718.
6. Alberts M.A., Bepler G., Hazelton T., et al. Practice organization. Chest 2003, 123:332S-337S.
7. Howard R.A. The Calman-Hine report: a personal retrospective on the UK's first comprehensive policy on cancer services. Lancet Oncol 2006, 7:336-346.
8. Griffith C., Turner J. United Kingdom National Health Service. Cancer Services Collaborative "Improvement Partnership", redesign of cancer services. A national approach. Eur J Surg Oncol 2004, 30:1-86.
9. Beattie G., Bannon F., McGuigan J. Lung cancer resection rates have increased significantly in females during a 15-year period. Eur J Cardiothorac Surg 2010, 38:484-490.
10. Conron M., Phuah S., Steinfort D., et al. Analysis of multidisciplinary lung cancer practice. Intern Med J 2007, 37:18-25.
11. Forrest L.M., McMillan D.C., McArdle C.S., et al. An evaluation of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 2005, 93:977-978.
12. Riedel R.F., Wang X., Cormack M., et al. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care. J Thorac Oncol 2006, 1:692-696.
13. Coory M., Gkolia P., Yang I.A., et al. Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer 2008, 60:14-21.
14. Bydder S., Nowak A., Marion K., et al. The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer. Intern Med J 2009, 39:838-848.
15. Boxer M.M., Vinot S.K., Shafiq J., et al. Do multidisciplinary team meetings make a difference in the management of lung cancer?. Cancer 2011, 117:5112-5120.
16. Stinchcombe T.E., Detterbeck M.D., Lin L., et al. Beliefs among physicians in the diagnostic and therapeutic approach to non-small cell lung cancer. J Thorac Oncol 2007, 2:819-826.
17. Vinod S.K., Sidhom M.A., Delaney G.P. Do multidisciplinary meetings follow guideline-based care?. J Oncol Pract 2010, 6:276-281.
18. Freeman R.K., Van Woerkom J.M., Vyverberg A., et al. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg 2010, 38:1-5.
19. Guillem P., Bolla M., Courby S., et al. Evaluation des reunions de concertation pluridisciplinaire en cancérologie: quelles priorités pour quelles ameliorations?. Bull Cancer 2011, 98:989-998.
20. Abbo O., Rivera C., Berjaud J., et al. Impact de la date de réunion de concertation pluridisciplinaire sur les délais de prise en charge des patients opérés pour cancer bronchopulmonaire primitif. Chirurgie thoracique Cardio-Vasculaire 2012, 16(1):7-10.
21. Ouwens M.M., Hermens R.R., Termeer R.A., et al. Quality of integrated care for patients with non-small cell lung cancer: variations and determinants of care. Cancer 2007, 110:1782-1790.
22. Bozcuk H., Martin C. Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer 2001, 34:243-252.
23. Aragoneses F.G., Moreno N., Leon P., Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S), et al. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 2002, 36:59-63.
24. Quarterman R.L., McMillan A., Ratcliffe M.B., et al. Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer. J Thorac Cardiovasc Surg 2003, 125(1):108-113.
25. Myrdal G., Lambe M., Hillerdal G., et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004, 59(1):45-49.
26. Salomaa E.R., Sällinen S., Hiekkanen H., et al. Delays in the diagnosis and treatment of lung cancer. Chest 2005, 128(4):2282-2288.
27. National Lung Screening Trial Research Team, Aberle D.R., Adams A.M., Berg C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365(5):395-409.
28. Catt S., Fallowfield L., Jenkins V., et al. The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK. Br J Cancer 2005, 93(10):1092-1097.
29. Fischel R.J., Dillman R.O. Developing an effective lung cancer program in a community hospital setting. Clin Lung Cancer 2009, 10:239-243.
30. Osarogiagbon R.U., Phelps G., McFarlane J., et al. Causes and consequences of deviation from multidisciplinary care in thoracic oncology. J Thorac Oncol 2011, 6:510-516.